The import of pharmaceutical goods to Indonesia has shown a general upward trend from 2013 to 2023, increasing from $24.38 million in 2013 to $58.621 million in 2023. This represents a compound annual growth rate (CAGR) of 7.93% over the entire period. While the growth was robust in the earlier years, peaking at 27.36% in 2017, it has slightly tapered off recently with a 3.93% year-on-year increase in 2023.
In the last two years, the growth has been more moderate, with a slight dip in 2022 (-0.78%) followed by a recovery in 2023. The forecast from 2024 onwards indicates continued growth, albeit at a lower CAGR of 2.54%, reaching $69.172 million by 2028.
Future trends to watch for:
- Impacts of new healthcare policies and regulations.
- Advancements in local pharmaceutical production reducing dependency on imports.
- Economic factors affecting purchasing power and healthcare funding.
- Global supply chain dynamics and geopolitical factors influencing trade.
